Twist Bioscience
Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.
Abveris
Acquisition in 2021
Abveris is a biotechnology company focused on the discovery of antibodies for both reagent and therapeutic applications. The company provides contract research services to the biopharma industry, utilizing advanced immunization techniques alongside B cell screening and hybridoma-based antibody discovery technologies. Abveris offers a comprehensive range of services that support antibody discovery, guiding projects from the initial design stage through to the final product delivery.
iGenomX
Acquisition in 2021
iGenomX is a developer of innovative sample preparation technology focused on enhancing clinical sequencing for recessive genetic disorders. Recognizing the limitations of existing commercial technologies, which often miss a significant portion of known causal mutations, the company aims to create a more comprehensive testing solution. Its technology improves DNA sequencing through advanced next-generation sequencing (NGS) library construction, benefiting various fields including population and disease genetics, agriculture, microbiome studies, and synthetic biology. By streamlining workflows and reducing costs, iGenomX enables clients to access valuable genetic data more efficiently.
Sphere Fluidics
Grant in 2017
Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.
Genome Compiler
Acquisition in 2016
Genome Compiler Corporation offers a software platform tailored for genetic engineers and synthetic biologists, facilitating DNA design, visualization, data management, and collaborative efforts. The platform includes tools for designing and debugging biological code, along with repositories for plasmids and parts, and connections to DNA synthesis providers. By integrating lab automation services, Genome Compiler enables users to efficiently create combinatorial designs for their projects. Incorporated in 2011 and based in Los Altos, California, Genome Compiler operates as a subsidiary of Twist Bioscience Corporation. Its solutions support professionals in biotechnology, agriculture, and pharmaceuticals, aiming to streamline the development of innovative, bio-based products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.